: Cerebral cavernous malformations (CCMs) of the brain are vascular lesions, which are present in up to 0.4% of the general population and often are accompanied by seizures, migraine, hemorrhagic stroke and other neurological outcomes. These lesions can occur sporadically, or as an autosomal dominant trait. Our group has recently identified the CCM1 gene, which is responsible for the majority of all familial CCMs and principally the cause for the familial form of CCMs in the Hispanic population (Sahoo et al., 1999). With the discovery of the CCM1 gene, we have developed a significant insight into the pathology of this """"""""familial stroke."""""""" There are two additional CCM genes that remain to be identified, CCM2 on chromosome 7p and CCM3 on chromosome 3q. We will utilize our previously successful approach for positional cloning, which employs a strong computational approach to transcript identification in order to identify positional candidates for sequencing. We believe that the resources will have accumulated and the approach we have established will allow us to identify the genes for CCM2 and CCM3. After identifying the genes responsible for CCM2 and CCM3, we will begin to investigate their role in the cell, and in particular, their role in the pathophysiology of CCM. These types of experiments include overall protein expression patterns in the embryo and the adult, cellular compartment localization studies, and a search for interacting proteins using the yeast two-hybrid screen. These data will provide the molecular/cellular framework from which to launch a more detailed analysis of these proteins in a future proposal. Our ultimate objective is to aid in understanding the fundamental mechanisms responsible for different forms of familial neurovascular disease. The availability of a model, where the primary genetic determinates have been identified unambiguously, will greatly expedite the search for the basic mechanisms involved in """"""""familial stroke"""""""" and to a better understanding of neurovascular disease, in general.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZNS1-SRB-S (01))
Program Officer
Golanov, Eugene V
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
Schools of Medicine
United States
Zip Code
McDonald, David A; Shenkar, Robert; Shi, Changbin et al. (2011) A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum Mol Genet 20:211-22
Akers, Amy L; Johnson, Eric; Steinberg, Gary K et al. (2009) Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet 18:919-30
Shenkar, Robert; Venkatasubramanian, Palamadai N; Wyrwicz, Alice M et al. (2008) Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models. Neurosurgery 63:790-7;discussion 797-8
Liquori, Christina L; Penco, Silvana; Gault, Judith et al. (2008) Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts. Neurogenetics 9:25-31
Liquori, Christina L; Berg, Michel J; Squitieri, Ferdinando et al. (2007) Deletions in CCM2 are a common cause of cerebral cavernous malformations. Am J Hum Genet 80:69-75
Liquori, Christina L; Berg, Michel J; Squitieri, Ferdinando et al. (2006) Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus. Hum Mutat 27:118
Plummer, Nicholas W; Squire, Teresa L; Srinivasan, Sudha et al. (2006) Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations. Mamm Genome 17:119-28
Zawistowski, Jon S; Stalheim, Lisa; Uhlik, Mark T et al. (2005) CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum Mol Genet 14:2521-31
Liquori, Christina L; Berg, Michel J; Siegel, Adrian M et al. (2003) Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 73:1459-64
Marchuk, Douglas A; Srinivasan, Sudha; Squire, Teresa L et al. (2003) Vascular morphogenesis: tales of two syndromes. Hum Mol Genet 12 Spec No 1:R97-112